198 related articles for article (PubMed ID: 1678563)
1. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
[TBL] [Abstract][Full Text] [Related]
3. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
4. Proglucagon processing similar to normal islets in pancreatic alpha-like cell line derived from transgenic mouse tumor.
Powers AC; Efrat S; Mojsov S; Spector D; Habener JF; Hanahan D
Diabetes; 1990 Apr; 39(4):406-14. PubMed ID: 2156740
[TBL] [Abstract][Full Text] [Related]
5. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
Drucker DJ; Asa SL; Silverberg J; Brubaker PL
Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
[TBL] [Abstract][Full Text] [Related]
6. Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene.
Brubaker PL; Lee YC; Drucker DJ
J Biol Chem; 1992 Oct; 267(29):20728-33. PubMed ID: 1328210
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagon-producing GLUTag transplantable tumor.
Drucker DJ; Lee YC; Asa SL; Brubaker PL
Mol Endocrinol; 1992 Dec; 6(12):2175-84. PubMed ID: 1491697
[TBL] [Abstract][Full Text] [Related]
8. Region- and age-specific differences in proglucagon gene expression in the central nervous system of wild-type and glucagon-simian virus-40 T-antigen transgenic mice.
Lee YC; Campos RV; Drucker DJ
Endocrinology; 1993 Jul; 133(1):171-7. PubMed ID: 8319563
[TBL] [Abstract][Full Text] [Related]
9. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression.
Rindi G; Grant SG; Yiangou Y; Ghatei MA; Bloom SR; Bautch VL; Solcia E; Polak JM
Am J Pathol; 1990 Jun; 136(6):1349-63. PubMed ID: 2162628
[TBL] [Abstract][Full Text] [Related]
10. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line.
Drucker DJ; Jin T; Asa SL; Young TA; Brubaker PL
Mol Endocrinol; 1994 Dec; 8(12):1646-55. PubMed ID: 7535893
[TBL] [Abstract][Full Text] [Related]
11. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
[TBL] [Abstract][Full Text] [Related]
12. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice.
Drucker DJ
Am J Physiol; 1994 Nov; 267(5 Pt 1):E629-35. PubMed ID: 7977712
[TBL] [Abstract][Full Text] [Related]
14. Do glucagonomas always produce glucagon?
Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
[TBL] [Abstract][Full Text] [Related]
15. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
Bani D; Bani Sacchi T; Biliotti G
Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
[TBL] [Abstract][Full Text] [Related]
16. Induction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker DJ; Erlich P; Asa SL; Brubaker PL
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7911-6. PubMed ID: 8755576
[TBL] [Abstract][Full Text] [Related]
17. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
18. On the contamination of commercially available aprotinins with pancreatic islet peptides.
Baldissera FG; Holst JJ
Scand J Clin Lab Invest; 1984 Nov; 44(7):669-72. PubMed ID: 6085188
[TBL] [Abstract][Full Text] [Related]
19. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
[TBL] [Abstract][Full Text] [Related]
20. Glicentin precedes glucagon in the developing human pancreas.
Stefan Y; Ravazzola M; Grasso S; Perrelet A; Orci L
Endocrinology; 1982 Jun; 110(6):2189-91. PubMed ID: 6122563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
